Medtronic wins CE mark for blood oxygenation system; Researchers develop advanced 'virtual' foot as treatment aid;

 @FierceMedDev: Tribogenics pulled in a $6.2M Series A round, to help develop portable X-ray sources for medical imaging. Release | Follow @FierceMedDev

 @MarkHFierce: Look at Teleflex, getting a 510(k) for a continuous peripheral nerve block catheter--a new anesthesia tool. Release | Follow @MarkHFierce

 @DamianFierce: Medtronic is making noise in India, appointing a new board member and committing $6M in grant money there. More | Follow @DamianFierce

> Medtronic ($MDT) obtained a CE mark in Europe for its new oxygenation system, designed to remove carbon dioxide from blood during open-heart surgery. Release

> As the device tax deadline gets closer, USA Today reminds us that some observers see the 2.3% excise tax as not hurting innovation or the discovery of new technologies in the least. Story

> Tribogenics closed a $6.2 million Series A round led by Founders Fund. The money will help fuel development of small, portable X-ray sources for medical imaging and other industries. Release

> GI Dynamics has expanded use of its EndoBarrier anti-obesity device to two new Australian clinics. Story

> Strand Diagnostics is rolling out a new product designed to protect breast biopsy patients from inaccurate diagnosis because biopsy samples are misidentified. Release

> Teleflex ($TFX) won 510(k) clearance for its latest continuous peripheral nerve block catheter, designed to be used for anesthesia and acute pain management. Release

> The FDA cleared Smiths Medical's new epidural administration safety system. Release

Biotech News

 @FierceBiotech: In case you missed it last week, check out our 2012 Fierce 15 report: Report | BPA 2012 Slideshow | Follow @FierceBiotech

 @JohnCFierce: Peregrine is now a penny stock company, down 85%. And somewhere lawyers are beginning a new day, aflutter with litigious thoughts. | Follow @JohnCFierce

 @RyanMFierce: Virtual R&D groups make sense in cases where a pharma might otherwise just pull the plug on R&D in a field like CNS. More | Follow @RyanMFierce

> Mallinckrodt swallows CNS Therapeutics' drug pipeline in $100M buyout. News

> Novo Nordisk boosts China R&D with $100M diabetes research project. Report

> Peregrine shares blasted after trial 'discrepancies' discredit lung cancer data. Article

Pharma News

 @FiercePharma: U.K.'s Rosemont Pharmaceuticals is up for sale. Value est. at £200M; specializes in liquid formulations--Sky NewsReport | Follow @FiercePharma

> Regeneron, Vertex, J&J score high in employer rankings. Item

> Questcor stock reels as feds eye Acthar marketing. News

> Warring Herceptin studies could cut treatment times--or boost them. More

> Moody's gives pharma a sigh of relief with 'Worst Is Over' outlook. Story

CRO News

> EU experts call for clinical trials to focus on the elderly. Report

> Big Pharmas unite to improve clinical development. Article

> CMOs move toward disposable manufacturing tech. More

> Covance taps big data outfit for diabetes R&D. Story

Biotech IT News

> Google VC unit angles for further life sciences investments. Article

> NYC startup Medikly caters to pharma interactions with docs. More

> Accelrys goes late-stage in R&D software game. Story

> AstraZeneca builds virtual neuroscience drug unit byte by byte. Report

And Finally... Researchers in Europe have developed an advanced virtual model of the human foot to enable treatment of foot-related injuries and illness. Story